APA

Lowe S. H., Wensing A. M. J., Hassink E. A. M., ten Kate R. W., Richter C., Schreij G., Koopmans P. P., Juttmann J. R., van der Tweel I., Lange J. M. A. & Borleffs J. C. C. (20060821). Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). : HIV clinical trials.

Chicago

Lowe S H, Wensing A M J, Hassink E A M, ten Kate R W, Richter C, Schreij G, Koopmans P P, Juttmann J R, van der Tweel I, Lange J M A and Borleffs J C C. 20060821. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). : HIV clinical trials.

Harvard

Lowe S. H., Wensing A. M. J., Hassink E. A. M., ten Kate R. W., Richter C., Schreij G., Koopmans P. P., Juttmann J. R., van der Tweel I., Lange J. M. A. and Borleffs J. C. C. (20060821). Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). : HIV clinical trials.

MLA

Lowe S H, Wensing A M J, Hassink E A M, ten Kate R W, Richter C, Schreij G, Koopmans P P, Juttmann J R, van der Tweel I, Lange J M A and Borleffs J C C. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). : HIV clinical trials. 20060821.